Evidence map›Paper›PMID 28587421›Full record

ArticleExperimental and therapeutic medicine2017

Effect of Suo Quan Wan on the bladder function of aging rats based on the β-adrenoceptor.

Yi-Fei Xu, Zhi-Jian Liang, Zhao-Jin Kuang, Jie-Jun Chen, Jun Wu, Xiang-E Lu, Wei-Wen Jiang, Ping-Long Fan, Li-Yao Tang, Yi-Tao Li and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Ginsenoside Rg1 protects against Sca-1Experimental and therapeutic medicine · 2020
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yi-Fei XuDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Zhi-Jian LiangDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Zhao-Jin KuangDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Jie-Jun ChenCenter for Drug Non-Clinical Evaluation and Research, Guangzhou General Pharmaceutical Research Institute, Guangzhou, Guangdong 510240, P.R. China.
Jun WuDepartment of Chinese Medicine, School of Chinese Medicine, Shandong College of Traditional Chinese Medicine, Yantai, Shandong 264199, P.R. China.
Xiang-E LuDepartment of Traditional Chinese Medicine, Institute of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China.
Wei-Wen JiangDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Ping-Long FanDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Li-Yao TangDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Yi-Tao LiDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Ping HuangDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Hong-Ying CaoDepartment of Chinese Medicine Pharmacology, School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China.
Guangzhou University of Chinese Medicine · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suo Quan Wan (SQW) has been used to treat lower urinary tract symptoms (LUTS) in elderly patients for hundreds of years in China. β-adrenoceptors (β-ARs), particularly β

Indexed as

aging ratbladder detrusorbladder dysfunctionSuo Quan Wanβ-adrenoceptor

Identifiers

PMID28587421
PMCPMC5450672
OpenAlexW2609446775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.